Sv7 Impact Medicine Fund Lp - Net Worth and Insider Trading
Sv7 Impact Medicine Fund Lp Net Worth
The estimated net worth of Sv7 Impact Medicine Fund Lp is at least $3 Million dollars as of 2024-05-28. Sv7 Impact Medicine Fund Lp is the 10% Owner of Xilio Therapeutics Inc and owns about 3,227,264 shares of Xilio Therapeutics Inc (XLO) stock worth over $3 Million. Details can be seen in Sv7 Impact Medicine Fund Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sv7 Impact Medicine Fund Lp has not made any transactions after 2021-10-26 and currently still holds the listed stock(s).
Transaction Summary of Sv7 Impact Medicine Fund Lp
Sv7 Impact Medicine Fund Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sv7 Impact Medicine Fund Lp owns 1 companies in total, including Xilio Therapeutics Inc (XLO) .
Click here to see the complete history of Sv7 Impact Medicine Fund Lp’s form 4 insider trades.
Insider Ownership Summary of Sv7 Impact Medicine Fund Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XLO | Xilio Therapeutics Inc | 2021-10-26 | 10 percent owner |
Sv7 Impact Medicine Fund Lp Latest Holdings Summary
Sv7 Impact Medicine Fund Lp currently owns a total of 1 stock. Sv7 Impact Medicine Fund Lp owns 3,227,264 shares of Xilio Therapeutics Inc (XLO) as of October 26, 2021, with a value of $3 Million.
Latest Holdings of Sv7 Impact Medicine Fund Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XLO | Xilio Therapeutics Inc | 2021-10-26 | 3,227,264 | 1.05 | 3,388,627 |
Holding Weightings of Sv7 Impact Medicine Fund Lp
Sv7 Impact Medicine Fund Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Sv7 Impact Medicine Fund Lp has made a total of 1 transactions in Xilio Therapeutics Inc (XLO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Xilio Therapeutics Inc is the acquisition of 625,000 shares on October 26, 2021, which cost Sv7 Impact Medicine Fund Lp around $10 Million.
Insider Trading History of Sv7 Impact Medicine Fund Lp
- 1
Sv7 Impact Medicine Fund Lp Trading Performance
GuruFocus tracks the stock performance after each of Sv7 Impact Medicine Fund Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sv7 Impact Medicine Fund Lp is -15.32%. GuruFocus also compares Sv7 Impact Medicine Fund Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sv7 Impact Medicine Fund Lp within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sv7 Impact Medicine Fund Lp's insider trading performs compared to the benchmark.
Performance of Sv7 Impact Medicine Fund Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 21.03 | | | | | |
| Relative Return to S&P 500(%) | 20.6 | | | | | |
Sv7 Impact Medicine Fund Lp Ownership Network
Sv7 Impact Medicine Fund Lp Owned Company Details
What does Xilio Therapeutics Inc do?
Who are the key executives at Xilio Therapeutics Inc?
Sv7 Impact Medicine Fund Lp is the 10 percent owner of Xilio Therapeutics Inc. Other key executives at Xilio Therapeutics Inc include 10 percent owner Atlas Venture Fund Xi, L.p. , Chief Medical Officer Katarina Luptakova , and Chief Operating Officer Christopher James Frankenfield .
Xilio Therapeutics Inc (XLO) Insider Trades Summary
Over the past 18 months, Sv7 Impact Medicine Fund Lp made no insider transaction in Xilio Therapeutics Inc (XLO). Other recent insider transactions involving Xilio Therapeutics Inc (XLO) include a net sale of 5,235 shares made by Atlas Venture Fund Xi, L.p. , and a net purchase of 485,250 shares made by Gilead Sciences Inc .
In summary, during the past 3 months, insiders sold 0 shares of Xilio Therapeutics Inc (XLO) in total and bought 485,250 shares, with a net purchase of 485,250 shares. During the past 18 months, 5,235 shares of Xilio Therapeutics Inc (XLO) were sold and 485,250 shares were bought by its insiders, resulting in a net purchase of 480,015 shares.
Xilio Therapeutics Inc (XLO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xilio Therapeutics Inc Insider Transactions
Sv7 Impact Medicine Fund Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Sv7 Impact Medicine Fund Lp. You might contact Sv7 Impact Medicine Fund Lp via mailing address: 71 Kingsway, London X0 Wc2b 6st.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
